12.43
price up icon2.90%   0.35
after-market Dopo l'orario di chiusura: 12.41 -0.02 -0.16%
loading
Precedente Chiudi:
$12.08
Aprire:
$12.26
Volume 24 ore:
91,667
Relative Volume:
0.47
Capitalizzazione di mercato:
$771.03M
Reddito:
-
Utile/perdita netta:
$-41.43M
Rapporto P/E:
-15.73
EPS:
-0.79
Flusso di cassa netto:
$-39.97M
1 W Prestazione:
-1.11%
1M Prestazione:
+9.13%
6M Prestazione:
+55.38%
1 anno Prestazione:
-16.07%
Intervallo 1D:
Value
$12.11
$12.65
Intervallo di 1 settimana:
Value
$10.96
$13.00
Portata 52W:
Value
$6.00
$20.50

Gh Research Plc Stock (GHRS) Company Profile

Name
Nome
Gh Research Plc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
50
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
GHRS's Discussions on Twitter

Confronta GHRS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GHRS
Gh Research Plc
12.43 779.69M 0 -41.43M -39.97M -0.79
Biotechnology icon
ONC
Beone Medicines Ltd Adr
258.27 26.01B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.85 114.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3499 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
83.98 6.29B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
484.93 63.90B 14.09B 4.50B 2.96B 39.28

Gh Research Plc Stock (GHRS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-04 Ripresa Cantor Fitzgerald Overweight
2025-03-13 Iniziato Guggenheim Buy
2025-03-07 Iniziato RBC Capital Mkts Outperform
2025-02-13 Iniziato Cantor Fitzgerald Overweight
2022-08-16 Iniziato H.C. Wainwright Buy
2022-06-16 Iniziato ROTH Capital Buy
Mostra tutto

Gh Research Plc Borsa (GHRS) Ultime notizie

pulisher
Jun 04, 2025

GHRS Stock Coverage Initiated with Positive Outlook | GHRS Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

cantor fitzgerald maintains overweight rating on gh research stock - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Takes $44,000 Position in GH Research PLC (NASDAQ:GHRS) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

How To Trade (GHRS) - news.stocktradersdaily.com

Jun 02, 2025
pulisher
Jun 02, 2025

Northern Trust Corp Has $286,000 Holdings in GH Research PLC (NASDAQ:GHRS) - Defense World

Jun 02, 2025
pulisher
May 27, 2025

GH Research to Present at ASCP Meeting on Breakthrough Depression Treatment - TipRanks

May 27, 2025
pulisher
May 22, 2025

(GHRS) Long Term Investment Analysis - news.stocktradersdaily.com

May 22, 2025
pulisher
May 21, 2025

GH Research to Present at ASCP Meeting on Depression Treatments - TipRanks

May 21, 2025
pulisher
May 21, 2025

GH Research PLC (NASDAQ:GHRS) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

May 21, 2025
pulisher
May 20, 2025

Beckley’s psychedelic reduces depression - BioWorld MedTech

May 20, 2025
pulisher
May 16, 2025

GH Research (NASDAQ:GHRS) Upgraded at Cantor Fitzgerald - Defense World

May 16, 2025
pulisher
May 15, 2025

GH Research (GHRS) Highlights Phase 2b Results at Clinical Confe - GuruFocus

May 15, 2025
pulisher
May 15, 2025

GH Research (GHRS) Highlights Phase 2b Results at Clinical Conference | GHRS Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

GH Research Showcases Promising Depression Treatment Data at ASCP Meeting - TipRanks

May 15, 2025
pulisher
May 15, 2025

GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting - Yahoo

May 15, 2025
pulisher
May 12, 2025

GH Research’s (GHRS) “Buy” Rating Reiterated at HC Wainwright - Defense World

May 12, 2025
pulisher
May 12, 2025

Guggenheim Cuts GH Research (NASDAQ:GHRS) Price Target to $29.00 - Defense World

May 12, 2025
pulisher
May 10, 2025

GH Research (GHRS) Price Target Lowered by Guggenheim | GHRS Sto - GuruFocus

May 10, 2025
pulisher
May 10, 2025

GHRS Stock: HC Wainwright & Co. Reiterates Buy Rating | GHRS Sto - GuruFocus

May 10, 2025
pulisher
May 09, 2025

GH Research: Promising Clinical Results and Strong Financial Position Justify Buy Rating - TipRanks

May 09, 2025
pulisher
May 09, 2025

GH Research (GHRS) Price Target Lowered by Guggenheim | GHRS Stock News - GuruFocus

May 09, 2025
pulisher
May 08, 2025

GH Research PLC Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

GHRS Reports Strong Financial Position with Increased Cash Holdi - GuruFocus

May 08, 2025
pulisher
May 08, 2025

GH Research Reports Q1 2025 Financial Results Amidst Ongoing Challenges - TipRanks

May 08, 2025
pulisher
May 08, 2025

GH Research PLC Reports Positive Phase 2b Trial Results for GH001 in Treatment-Resistant Depression and Financial Update for Q1 2025 - Nasdaq

May 08, 2025
pulisher
May 08, 2025

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - Stock Titan

May 08, 2025
pulisher
May 05, 2025

What Makes GH Research (GHRS) a New Buy Stock - Yahoo Finance

May 05, 2025
pulisher
May 01, 2025

Where are the Opportunities in (GHRS) - news.stocktradersdaily.com

May 01, 2025
pulisher
May 01, 2025

Hims & Hers Health (NYSE:HIMS) Shares Down 8.3% Following Insider Selling - American Banking and Market News

May 01, 2025
pulisher
Apr 21, 2025

Legal & General Group Plc Sells 18,302 Shares of Guardant Health, Inc. (NASDAQ:GH) - Defense World

Apr 21, 2025
pulisher
Apr 18, 2025

What Will GH Research PLC (NASDAQ: GHRS) Be Like In 2025 - Stocksregister

Apr 18, 2025
pulisher
Apr 16, 2025

Psyence BioMed invests half a million into natural psychedelics operator PsyLabs - Mugglehead Magazine

Apr 16, 2025
pulisher
Apr 16, 2025

(GHRS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Apr 16, 2025
pulisher
Mar 31, 2025

(GHRS) Proactive Strategies - news.stocktradersdaily.com

Mar 31, 2025
pulisher
Mar 20, 2025

JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Mar 20, 2025
pulisher
Mar 13, 2025

Guggenheim starts GH Research at Buy, sees long-term upside potential - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Mar 13, 2025
pulisher
Mar 11, 2025

GH Research PLC (GHRS) Shares Rise Despite Market Challenges - The News Heater

Mar 11, 2025
pulisher
Mar 10, 2025

How to Take Advantage of moves in (GHRS) - news.stocktradersdaily.com

Mar 10, 2025
pulisher
Mar 10, 2025

GH Research (NASDAQ:GHRS) Earns Outperform Rating from Analysts at Royal Bank of Canada - Defense World

Mar 10, 2025
pulisher
Mar 10, 2025

GH Research PLC (NASDAQ:GHRS) Receives $30.67 Consensus PT from Brokerages - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

Q1 Earnings Forecast for GH Research Issued By HC Wainwright - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

RBC Capital Initiates Coverage of GH Research (GHRS) with Outperform Recommendation - Nasdaq

Mar 07, 2025
pulisher
Mar 07, 2025

FY2029 EPS Estimates for GH Research Lifted by HC Wainwright - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

GH Research initiated with an Outperform at RBC Capital - TipRanks

Mar 07, 2025
pulisher
Mar 05, 2025

GH Research PLC Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

H.C. Wainwright maintains $40 target on GH Research stock By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

H.C. Wainwright maintains $40 target on GH Research stock - Investing.com

Mar 05, 2025
pulisher
Mar 04, 2025

Postpartum Depression Pipeline Revealed in 2025 Forecast Report Featuring GH Research, Reunion Neuroscience, Lipocine, and Brii Biosciences - GlobeNewswire Inc.

Mar 04, 2025
pulisher
Mar 03, 2025

Why GH Research PLC (GHRS) is Skyrocketing So Far in 2025 - MSN

Mar 03, 2025
pulisher
Mar 01, 2025

Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Mar 01, 2025

Gh Research Plc Azioni (GHRS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.16
price up icon 0.00%
$573.50
price down icon 0.54%
$36.08
price up icon 15.90%
$305.31
price up icon 0.51%
$4.75
price up icon 3.70%
$484.93
price down icon 0.60%
Capitalizzazione:     |  Volume (24 ore):